Lidocaine / Mepivacaine (Local Infiltration — Plastics)
Brand names: Xylocaine (lidocaine), Scandonest (mepivacaine)
Lidocaine and mepivacaine are amide local anaesthetics used for local infiltration in plastic surgery to provide field anaesthesia for minor procedures and wound work.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Both reversibly block neuronal voltage-gated sodium channels, halting impulse conduction; mepivacaine has a duration broadly similar to lidocaine and, unlike lidocaine, produces little local vasodilatation.
Prescribing in practice
- Inadvertent intravascular injection or excessive total dose can precipitate local-anaesthetic systemic toxicity with CNS and cardiovascular collapse, so aspirate before injecting, use the lowest effective dose and keep lipid emulsion available.
- If a preparation contains adrenaline, avoid infiltration around digits, nose, ears and other end-arterial territories where ischaemia is a concern.
- Reduce dose in hepatic impairment, the elderly and the debilitated, in whom amide clearance and tolerance are reduced.
Monitoring
Monitor for early signs of systemic toxicity during and after infiltration, particularly when larger volumes are used, with resuscitation equipment to hand.
Counselling the patient
- Numbness and loss of sensation in the area are expected and wear off over a few hours.
- Tell the team immediately if you feel dizzy, hear ringing, notice a metallic taste or feel your heart racing.
Evidence & guidelines
Maximum-dose limits and management of local-anaesthetic systemic toxicity with lipid emulsion are established in UK anaesthetic safety guidance.
Reference: AAGBI Local Anaesthetic Toxicity Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- ASA Physical Status Classification · Pre-operative Risk
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- NYHA Heart Failure Classification · Heart Failure
- GRACE ACS Risk Score · Acute Coronary Syndrome
- MAGGIC Heart Failure Risk Score · Heart Failure
- WHO Functional Classification (Pulmonary Hypertension) · Pulmonary Hypertension
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH